Key populations brief
Accessed November 2017
Working Document, September 2017
Adapted from a fact sheet on TB from the International Council of Nurse’s Global TB/MDR-TB Resource Centre at: http://www.icn.ch/tb/stigma.htm.
Accessed November 2017
Key populations brief
Accessed 2017
СЕЛЬСКОЕ НАСЕЛЕНИЕ
ОСНОВНЫЕ ЗАТРОНУТЫЕ ГРУППЫ НАСЕЛЕНИЯ. КРАТКОЕ РУКОВОДСТВО.
Во всем мире распространенность туберкулеза гораздо выше
в городских районах, чем в сельских. Около 54 % мирового населения
проживает в городах, а развивающиеся ст...аны показывают наиболее
высокие темпы урбанизации. В развитых странах урбанизация привела
к всеобщему улучшению здравоохранения, однако данная тенденция
не нашла отражения в менее развитых регионах мира. В таких странах
ключевые социальные и экономические детерминанты туберкулеза
сходятся на самых бедных группах населения. краткое руководство
Accessed on 2017
more
Key populations brief
Accessed 2017
Scientific advice
Prevention and control of communicable diseases in prison settings.
The modules (1-12) are based on materials originally developed by FIND, KNCV and Cepheid, and are in PowerPoint format for country customization. Depending on the audience, modules may be selected and adapted according to need (e.g. basic users, supervisors, clinicians). Topics covered include: Over...view of TB and diagnostics, biosafety, specimen collection, procurement, installation, Xpert MTB/RIF technology, results interpretation, reporting, troubleshooting, maintenance, a clinical guide, and quality assurance.
Please download each manual directliy from the website
more
Key Populations Brief
Accessed November 2017
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...rest to managers of maternal, newborn and child health programmes and sexual and reproductive health programmes, international and bilateral agencies, and organizations that provide financial and technical support to the relevant national health programmes.
more
Lessons from the STEP-TB Project.
Accessed November 2017.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996